[1]
|
师辰燕, Mamal, A., 刘增慧, 吴晓雄, 夏凌辉, 聂大年, 赖永榕, 等. 重型再生障碍性贫血行异基因造血干细胞移植后植入功能不良的危险因素分析[J]. 中华血液学杂志, 38(9): 761-766.
https://doi.org/10.3760/cma.j.issn.0253-2727.2017.09.006
|
[2]
|
林果为, 王吉耀, 葛均波. 实用内科学[M]. 第15版. 北京: 人民卫生出版社, 2017: 2.
|
[3]
|
Yuan, K. (2019) Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation—An Old Complication with New Insights. Seminars in Hematology, 56, 215-220. https://doi.org/10.1053/j.seminhematol.2018.08.004
|
[4]
|
Zhao, Y.M., Gao, F., Shi, J.M., Luo, Y., Tan, Y.M., Lai, X.Y., et al. (2019) Incidence, Risk Factors, and Outcomes of Primary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation, 25, 1898-1907. https://doi.org/10.1016/j.bbmt.2019.05.036
|
[5]
|
韩明哲. 异基因造血干细胞移植后植入功能不良研究进展[J]. 临床血液学杂志, 2019, 32(9): 660-664.
http://dx.chinadoi.cn/10.13201/j.issn.1004-2806.2019.09.003
|
[6]
|
Sun, Y.Q., He, G.L., Chang, Y.J., Xu, L.-P., Zhang, X.-H., Han, W., et al. (2015) The Incidence, Risk Factors, and Outcomes of Primary Poor Graft Function after Unmanipulated Haploidentical Stem Cell Transplantation. Annals of Hematology, 94, 1699-705. https://doi.org/10.1007/s00277-015-2440-x
|
[7]
|
Mainardi, C., Ebinger, M., Enkel, S., Feuchtinger, T., Teltschik, H.-M., Eyrich, M., et al. (2018) CD34+ Selected Stem Cell Boosts Can Improve Poor Graft Function after Paediatric Allogeneic Stem Cell Transplantation. British Journal of Haematology, 180, 90-99. https://doi.org/10.1111/bjh.15012
|
[8]
|
Xiao, Y., Song, J.Y., Jiang, Z.J., Li, Y.H., Gao, Y., Xu, W.N., et al. (2014) Risk-Factor Analysis of Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation. International Journal of Medical Sciences, 11, 652-657. https://doi.org/10.7150/ijms.6337
|
[9]
|
Rowley, S.D., Liang, P.S. and Ulz, L. (2000) Transplantation of ABO-Incompatible Bone Marrow and Peripheral Blood Stem Cell Components. Bone Marrow Transplant, 26, 749-757. https://doi.org/10.1038/sj.bmt.1702572
|
[10]
|
Benjamin, R.J., Connors, J.M., McGurk, S., Hallowell Churchill, W. and Antin, J.H (1998) Prolonged Erythroid Aplasia after Major ABO-Mismatched Transplantation for Chronic Myelogenous Leukemia. Biol Blood Marrow Transplant, 4, 151-156. https://doi.org/10.1053/bbmt.1998.v4.pm9923413
|
[11]
|
Torok-Storb, B., Boeckh, M., Hoy, C., Leisenring, W., Myerson, D. and Gooley, T. (1997) Association of Specific Cytomegalovirus Genotypes with Death from Myelosuppression after Marrow Transplantation. Blood, 90, 2097-102.
|
[12]
|
Song, Y., Zhao, H.Y., Lyu, Z.S., Cao, X.-N., Shi, M.-M., Wen, Q., et al. (2018) Dysfunctional Bone Marrow Mesenchymal Stem Cells in Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation, 24, 1981-1989. https://doi.org/10.1016/j.bbmt.2018.06.021
|
[13]
|
Mohty, R., Brissot, E., Battipaglia, G., Ruggeri, A., Sestili, S., Mediavilla, C., et al. (2019) CD34+-Selected Stem Cell “Boost” for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation. Current Research in Translational Medicine, 67, 112-114. https://doi.org/10.1016/j.retram.2018.12.003
|
[14]
|
刘晓丹, 范志平, 彭延文, 黄芬, 江千里, 张贤, 等. 第三方骨髓间充质干细胞治疗异基因造血干细胞移植后植入功能不良[J]. 中华血液学杂志, 2011, 33(2): 98-102.
http://dx.chinadoi.cn/10.3760/cma.j.issn.0253-2727.2012.02.007
|
[15]
|
Olivieri, J., Mancini, G., Goteri, G., Scortechini, I., Giantomassi, F., Chiarucci, M. (2016) Reversal of Poor Graft Function with Iron-Chelating Therapy after Allogeneic Transplantation for Severe Aplastic Anemia. Leukemia & Lymphoma, 57, 965-968. https://doi.org/10.3109/10428194.2015.1085530
|
[16]
|
Wei, J., Xiao, Y., Yu, X., Zhou, J. and Zhang, Y. (2010) Early Onset of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) after Allogeneic Haematopoietic Stem Cell Transplantation: Case Report and Review of the Literature. Journal of International Medical Research, 38, 705-710. https://doi.org/10.1177/147323001003800235
|
[17]
|
Paul, G., John, A., Pierre-Marc, B., Cohen, M., Cranston, I., Murray, R.D., et al. (2015) The Diagnosis and Management of Inpatient Hyponatraemia and SIADH. European Journal of Clinical Investigation, 45, 888-894.
https://doi.org/10.1111/eci.12465
|
[18]
|
江倩, 刘开彦, 黄晓军, 卢纹凯. 异基因造血干细胞移植后的抗利尿激素分泌失调综合征一例报告——附文献复习[J]. 中华血液学杂志, 2006(2): 78-81.
|
[19]
|
邹德慧, 王东浩, 王迎, 赵耀中, 薛华, 李妍, 等. 非亲缘异基因造血干细胞移植后的血管升压素分泌失调综合征[J]. 中华内科杂志, 2006, 45(10): 853-854. http://dx.chinadoi.cn/10.3760/j.issn:0578-1426.2006.10.023
|
[20]
|
张翔, 肖毅, 张义成, 耿哲, 周剑峰, 余学锋, 等. 异基因造血干细胞移植后抗利尿激素分泌失调综合征诊治体会[J]. 内科急危重症杂志, 2009, 15(3): 161-163. http://dx.chinadoi.cn/10.3969/j.issn.1007-1024.2009.03.018
|
[21]
|
肖毅, 张义成, 隗佳, 孙汉英, 刘文励, 周剑峰. 异基因造血干细胞移植后的抗利尿激素分泌失调综合征[C]//中国病理生理学会实验血液学专业委员会. 第12届全国实验血液学会议论文摘要. 中国病理生理学会实验血液学专业委员会: 中国病理生理学会, 2009: 1.
|
[22]
|
Rau, R., Fitzhugh, C.D., Baird, K., Cortez, K.J., Li, L., Fischer, S.H., et al. (2008) Triad of Severe Abdominal Pain, Inappropriate Antidiuretic Hormone Secretion, and Disseminated Varicella-Zoster Virus Infection Preceding Cutaneous Manifestations After Hematopoietic Stem Cell Transplantation: Utility of PCR for Early Recognition and Therapy. The Pediatric Infectious Disease Journal, 27, 265-268. https://doi.org/10.1097/INF.0b013e31815cb239
|
[23]
|
Peri, A., Pirozzi, N., Parenti, G., Festuccia, F. and Menè, P. (2010) Hyponatremia and the Syndrome of Inappropriate Secretion of Antidiuretic Hormone (SIADH). Journal of Endocrinological Investigation, 33, 671-682.
https://doi.org/10.1007/BF03346668
|
[24]
|
李银英, 邱磊, 王淑亮. 抗利尿激素分泌失调综合征临床研究现状[J]. 继续医学教育, 2017, 31(6): 74-76.
|
[25]
|
邵珠林, 徐向进. 结合指南看抗利尿激素分泌异常综合征的最新诊疗进展[J]. 内科急危重症杂志, 2016, 22(4): 247-249.
|